Jonathan Slonin, Chief Clinical Officer at Pacira BioSciences, Inc. (PCRX), sold 961 shares at $38.99 ($37K) on 2023-06-06, disclosed to the SEC on 2023-06-07.
Open-market sale of $37k PCRX by Chief Clinical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.99 | 471 | $18K | 49.7% |
| 2 | $37.87 | 490 | $19K | 50.3% |
| Total | $38.42 avg | 961 | $37K | 100% |
| Filing → |
| PCRX | SELL | 2025-11-19 | $191K | — | Filing → |
| PCRX | SELL | 2025-01-06 | $16K | — | Filing → |
| PCRX | SELL | 2024-08-02 | $19K | — | Filing → |